85,015
XNAS Volume
High volume+loss today
XNAS 28 Mar, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Irit Arbel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2025 | 30,666 | 41,054 (0%) | 0% | 0 | Common Stock | |
| Hartoun Hartounian | EVP, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2025 | 50,000 | 52,000 (0%) | 0% | 0 | Common Stock | |
| Jacob A. Frenkel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2025 | 40,000 | 43,777 (0%) | 0% | 0 | Common Stock | |
| Chaim Lebovits | President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2025 | 120,000 | 200,960 (0%) | 0% | 0 | Common Stock | |
| Uri Yablonka | Director, EVP & Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2025 | 40,000 | 48,464 (0%) | 0% | 0 | Common Stock | |
| Uri Yablonka | Director, EVP & Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2025 | 20,000 | 68,464 (0%) | 0% | 0 | Common Stock | |
| Alla Patlis | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2025 | 40,000 | 44,349 (0%) | 0% | 0 | Common Stock | |
| Anthony J. Polverino | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2025 | 24,000 | 25,730 (0%) | 0% | 0 | Common Stock | |
| Stacy R. Lindborg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2025 | 20,000 | 48,229 (0%) | 0% | 0 | Common Stock | |
| Menghisteab Bairu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2025 | 24,000 | 24,000 (0%) | 0% | 0 | Common Stock | |
| Nir Naor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2025 | 30,666 | 31,465 (0%) | 0% | 0 | Common Stock | |
| Ibrahim B. Dagher | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2025 | 50,000 | 66,849 (0%) | 0% | 0 | Common Stock | |
| Chaim Lebovits | President & CEO | Purchase of securities on an exchange or from another person at price $ 3.43 per share. | 30 Sep 2024 | 1,836 | 80,960 (0%) | 0% | 3.4 | 6,292 | Common Stock |
| Chaim Lebovits | President & CEO | Purchase of securities on an exchange or from another person at price $ 0.23 per share. | 30 Sep 2024 | 22,000 | 1,186,865 (4%) | 0% | 0.2 | 5,016 | Common Stock |
| Ibrahim B. Dagher | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 0.35 per share. | 19 Jul 2024 | 63,000 | 0 (0%) | 0% | 0.4 | 22,069 | Common Stock |
| Haro Hartounian | EVP, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2024 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
| Haro Hartounian | EVP, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2024 | 30,000 | 30,000 (0%) | 0% | 0 | Common Stock | |
| Chaim Lebovits | President & CEO | Grant, award, or other acquisition of securities at price $ 0.52 per share. | 28 May 2024 | 15,000 | 1,164,865 (4%) | 0% | 0.5 | 7,775 | Common Stock |
| Chaim Lebovits | President & CEO | Purchase of securities on an exchange or from another person at price $ 0.52 per share. | 28 May 2024 | 15,000 | 1,164,865 (4%) | 0% | 0.5 | 7,775 | Common Stock |
| Chaim Lebovits | President & CEO | Grant, award, or other acquisition of securities at price $ 0.58 per share. | 21 May 2024 | 25,000 | 1,124,865 (4%) | 0% | 0.6 | 14,475 | Common Stock |
| Chaim Lebovits | President & CEO | Grant, award, or other acquisition of securities at price $ 0.64 per share. | 21 May 2024 | 25,000 | 1,149,865 (4%) | 0% | 0.6 | 16,000 | Common Stock |
| Chaim Lebovits | President & CEO | Purchase of securities on an exchange or from another person at price $ 0.58 per share. | 21 May 2024 | 25,000 | 1,124,865 (4%) | 0% | 0.6 | 14,475 | Common Stock |
| Chaim Lebovits | President & CEO | Purchase of securities on an exchange or from another person at price $ 0.64 per share. | 21 May 2024 | 25,000 | 1,149,865 (4%) | 0% | 0.6 | 16,000 | Common Stock |
| Chaim Lebovits | President & CEO | Grant, award, or other acquisition of securities at price $ 0.47 per share. | 10 May 2024 | 10,000 | 1,089,865 (4%) | 0% | 0.5 | 4,665 | Common Stock |
| Chaim Lebovits | President & CEO | Grant, award, or other acquisition of securities at price $ 0.46 per share. | 10 May 2024 | 20,000 | 1,079,865 (4%) | 0% | 0.5 | 9,300 | Common Stock |
| Chaim Lebovits | President & CEO | Grant, award, or other acquisition of securities at price $ 0.49 per share. | 10 May 2024 | 10,000 | 1,099,865 (4%) | 0% | 0.5 | 4,900 | Common Stock |
| Chaim Lebovits | President & CEO | Purchase of securities on an exchange or from another person at price $ 0.46 per share. | 10 May 2024 | 20,000 | 1,079,865 (4%) | 0% | 0.5 | 9,300 | Common Stock |
| Chaim Lebovits | President & CEO | Purchase of securities on an exchange or from another person at price $ 0.47 per share. | 10 May 2024 | 10,000 | 1,089,865 (4%) | 0% | 0.5 | 4,665 | Common Stock |
| Chaim Lebovits | President & CEO | Purchase of securities on an exchange or from another person at price $ 0.49 per share. | 10 May 2024 | 10,000 | 1,099,865 (4%) | 0% | 0.5 | 4,900 | Common Stock |
| Chaim Lebovits | President & CEO | Grant, award, or other acquisition of securities at price $ 0.37 per share. | 07 May 2024 | 66,300 | 1,059,865 (4%) | 0% | 0.4 | 24,816 | Common Stock |
| Chaim Lebovits | President & CEO | Purchase of securities on an exchange or from another person at price $ 0.37 per share. | 07 May 2024 | 66,300 | 1,059,865 (4%) | 0% | 0.4 | 24,816 | Common Stock |
| Chaim Lebovits | President & CEO | Grant, award, or other acquisition of securities at price $ 0.38 per share. | 06 May 2024 | 135,000 | 993,565 (3%) | 0% | 0.4 | 50,666 | Common Stock |
| Chaim Lebovits | President & CEO | Purchase of securities on an exchange or from another person at price $ 0.38 per share. | 06 May 2024 | 135,000 | 993,565 (3%) | 0% | 0.4 | 50,666 | Common Stock |
| Chaim Lebovits | President & CEO | Grant, award, or other acquisition of securities at price $ 0.52 per share. | 19 Apr 2024 | 15,000 | 858,565 (3%) | 0% | 0.5 | 7,799 | Common Stock |
| Chaim Lebovits | President & CEO | Purchase of securities on an exchange or from another person at price $ 0.52 per share. | 19 Apr 2024 | 15,000 | 858,565 (3%) | 0% | 0.5 | 7,799 | Common Stock |
| Chaim Lebovits | President & CEO | Grant, award, or other acquisition of securities at price $ 0.53 per share. | 17 Apr 2024 | 115,072 | 843,565 (3%) | 0% | 0.5 | 60,470 | Common Stock |
| Chaim Lebovits | President & CEO | Grant, award, or other acquisition of securities at price $ 0.55 per share. | 17 Apr 2024 | 130,000 | 728,493 (2%) | 0% | 0.5 | 70,941 | Common Stock |
| Chaim Lebovits | President & CEO | Purchase of securities on an exchange or from another person at price $ 0.55 per share. | 17 Apr 2024 | 130,000 | 728,493 (2%) | 0% | 0.5 | 70,941 | Common Stock |
| Chaim Lebovits | President & CEO | Purchase of securities on an exchange or from another person at price $ 0.53 per share. | 17 Apr 2024 | 115,072 | 843,565 (3%) | 0% | 0.5 | 60,470 | Common Stock |
| Chaim Lebovits | President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2024 | 305,198 | 598,493 (2%) | 1% | 0 | Common Stock | |
| Uri Yablonka | Director, EVP & Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2024 | 109,426 | 126,969 (0%) | 0% | 0 | Common Stock | |
| Alla Patlis | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2024 | 65,246 | 65,246 (0%) | 0% | 0 | Common Stock | |
| Stacy R. Lindborg | Co-Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2024 | 241,935 | 423,435 (1%) | 0% | 0 | Common Stock | |
| Chaim Lebovits | President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2023 | 31,185 | 293,295 (1%) | 0% | 0 | Common Stock | |
| Stacy R. Lindborg | Co-Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2023 | 35,000 | 170,000 (0%) | 0% | 0 | Common Stock | |
| Nir Naor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jun 2023 | 11,999 | 11,999 (0%) | 0% | 0 | Common Stock | |
| Kirk Taylor | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2023 | 80,000 | 80,000 | - | - | Stock Option (right to buy) | |
| Kirk Taylor | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2023 | 35,000 | 35,000 (0%) | 0% | 0 | Common Stock | |
| Chaim Lebovits | President & Co-CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Apr 2023 | 75,000 | 262,110 (0%) | 0% | 0 | Common Stock | |
| Stacy R. Lindborg | Co-Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Apr 2023 | 75,000 | 135,000 (0%) | 0% | 0 | Common Stock | |
| Stacy R. Lindborg | Co-Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Dec 2022 | 35,000 | 60,000 (0%) | 0% | 0 | Common Stock | |
| Chaim Lebovits | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Sep 2022 | 31,185 | 187,110 (0%) | 0% | 0 | Common Stock | |
| Jacob A. Frenkel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Apr 2022 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
| Ralph Kern | COO and Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2022 | 35,885 | 223,310 (0%) | 0% | 0 | Common Stock | |
| Anthony J. Polverino | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 3,882 | 25,960 (0%) | 0% | 0 | Common Stock | |
| Preetam Shah | EVP, CFO and Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.64 per share. | 30 Dec 2020 | 25,000 | 11,600 (0%) | 0% | 4.6 | 116,000 | Common Stock |
| Stacy Lindborg | EVP, Head Global Clin Research | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 17 Nov 2020 | 200 | 200 | - | - | Call Option (right to buy) | |
| Anthony Waclawski | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Sep 2020 | 35,000 | 35,000 (0%) | 0% | 0 | Common Stock | |
| Anthony Waclawski | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Sep 2020 | 80,000 | 80,000 | - | - | Stock Option (Right to Buy) | |
| Chaim Lebovits | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jul 2020 | 31,185 | 124,740 (0%) | 0% | 0 | Common Stock | |
| David Setboun | EVP and COO | Purchase of securities on an exchange or from another person at price $ 12.95 per share. | 16 Jul 2020 | 5,000 | 55,000 (0%) | 0% | 12.9 | 64,740 | Common Stock |
| Sankesh Abbhi | Director | Purchase of securities on an exchange or from another person at price $ 12.99 per share. | 15 Jul 2020 | 46,779 | 2,164,530 (8%) | 0% | 13.0 | 607,659 | Common Stock |
| Uri Yablonka | Director, EVP & Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2020 | 10,000 | 17,543 (0%) | 0% | 0 | Common Stock | |
| Stacy Lindborg | EVP, Head Global Clin Research | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2020 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | |
| Stacy Lindborg | EVP, Head Global Clin Research | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2020 | 25,000 | 25,000 (0%) | 0% | 0 | Common Stock | |
| David Setboun | EVP and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Apr 2020 | 50,000 | 50,000 (0%) | 0% | 0 | Common Stock | |
| Jacob A. Frenkel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Apr 2020 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
| Sankesh Abbhi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Apr 2020 | 4,657 | 4,657 (0%) | 0% | 0 | Common Stock | |
| Ralph Kern | COO and Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2020 | 80,000 | 80,000 | - | - | Stock Option (right to buy) | |
| Ralph Kern | COO and Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2020 | 35,885 | 151,540 (0%) | 0% | 0 | Common Stock | |
| Arturo O. Araya | Chief Commercial Officer | Purchase of securities on an exchange or from another person at price $ 3.90 per share. | 24 Dec 2019 | 3,000 | 8,608 (0%) | 0% | 3.9 | 11,700 | Common Stock |
| Ralph Kern | COO and Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 3.88 per share. | 24 Dec 2019 | 3,000 | 115,655 (0%) | 0% | 3.9 | 11,640 | Common Stock |
| Preetam Shah | EVP, CFO and Treasurer | Purchase of securities on an exchange or from another person at price $ 3.96 per share. | 24 Dec 2019 | 11,600 | 36,600 (0%) | 0% | 4.0 | 45,929 | Common Stock |
| Irit Arbel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2019 | 25,333 | 25,333 | - | - | Stock Option (right to buy) | |
| Malcolm S. Taub | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2019 | 12,000 | 53,332 (0%) | 0% | 0 | Common Stock | |
| June S. Almenoff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2019 | 2,000 | 2,000 (0%) | 0% | 0 | Common Stock | |
| Uri Yablonka | Director, EVP and Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2019 | 13,333 | 13,333 | - | - | Stock Option (right to buy) | |
| Anthony J. Polverino | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2019 | 3,071 | 15,862 (0%) | 0% | 0 | Common Stock | |
| Anthony J. Polverino | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2019 | 2,000 | 12,791 (0%) | 0% | 0 | Common Stock | |
| Preetam Shah | EVP, CFO and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Sep 2019 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | |
| Preetam Shah | EVP, CFO and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Sep 2019 | 25,000 | 25,000 (0%) | 0% | 0 | Common Stock | |
| Preetam Shah | EVP, CFO and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Sep 2019 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | |
| Irit Arbel | Director | Sale of securities on an exchange or to another person at price $ 3.67 per share. | 28 Aug 2019 | 13,332 | 155,833 (0%) | 0% | 3.7 | 48,891 | Common Stock |
| Irit Arbel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Aug 2019 | 6,666 | 0 | - | - | Stock Option (right to buy) | |
| Irit Arbel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Aug 2019 | 6,666 | 0 | - | - | Stock Option (right to buy) | |
| Irit Arbel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.25 per share. | 28 Aug 2019 | 6,666 | 169,165 (0%) | 0% | 2.3 | 14,999 | Common Stock |
| Irit Arbel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.25 per share. | 28 Aug 2019 | 6,666 | 162,499 (0%) | 0% | 2.3 | 14,999 | Common Stock |
| Chaim Lebovits | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jul 2019 | 31,185 | 2,166,155 (8%) | 0% | 0 | Common Stock | |
| Ralph Kern | COO and Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2019 | 35,885 | 112,655 (0%) | 0% | 0 | Common Stock | |
| Anthony J. Polverino | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2019 | 3,501 | 10,791 (0%) | 0% | 0 | Common Stock | |
| June S. Almenoff | Director | Purchase of securities on an exchange or from another person at price $ 3.39 per share. | 04 Jan 2019 | 1,475 | 7,175 (0%) | 0% | 3.4 | 5,000 | Common Stock |
| Chen Schor | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2018 | 2,000 | 125,558 (0%) | 0% | 0 | Common Stock | |
| Irit Arbel | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2018 | 25,333 | 25,333 | - | - | Stock Option (right to buy) | |
| Malcolm S. Taub | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2018 | 12,000 | 41,332 (0%) | 0% | 0 | Common Stock | |
| Uri Yablonka | Director, EVP and Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2018 | 13,333 | 13,333 | - | - | Stock Option (right to buy) | |
| Anthony J. Polverino | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2018 | 2,000 | 5,623 (0%) | 0% | 0 | Common Stock | |
| Anthony J. Polverino | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2018 | 1,667 | 7,290 (0%) | 0% | 0 | Common Stock | |
| Chen Schor | None | Gift of securities by or to the insider at price $ 0.00 per share. | 24 Oct 2018 | 121,558 | 4,000 (0%) | 0% | 0 | Common Stock | |
| Chen Schor | None | Gift of securities by or to the insider at price $ 0.00 per share. | 24 Oct 2018 | 121,558 | 121,558 (0%) | 0% | 0 | Common Stock | |
| Arturo O. Araya | Director, Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Aug 2018 | 200,000 | 200,000 | - | - | Stock Option (right to buy) | |
| Arturo O. Araya | Director, Chief Commercial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 28 Aug 2018 | 2,805 | 5,608 (0%) | 0% | 0 | Common Stock | |
| Chaim Lebovits | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jul 2018 | 31,185 | 2,134,970 (10%) | 0% | 0 | Common Stock | |
| Arturo O. Araya | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Mar 2018 | 1,249 | 8,413 (0%) | 0% | 0 | Common Stock | |
| June S. Almenoff | None | Purchase of securities on an exchange or from another person at price $ 3.50 per share. | 15 Mar 2018 | 5,700 | 5,700 (0%) | 0% | 3.5 | 19,950 | Common Stock |
| Ralph Kern | COO and Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 3.60 per share. | 15 Mar 2018 | 5,000 | 40,885 (0%) | 0% | 3.6 | 17,997 | Common Stock |
| Ralph Kern | COO and Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2018 | 35,885 | 76,770 (0%) | 0% | 0 | Common Stock | |
| Arturo O. Araya | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2018 | 4,152 | 7,164 (0%) | 0% | 0 | Common Stock | |
| Anthony J. Polverino | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2018 | 3,623 | 3,623 (0%) | 0% | 0 | Common Stock | |
| Eyal Rubin | CFO and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2017 | 25,000 | 25,000 (0%) | 0% | 0 | Common Stock | |
| Eyal Rubin | CFO and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2017 | 93,686 | 93,686 | - | - | Stock Option (right to buy) | |
| Chen Schor | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Nov 2017 | 2,000 | 123,558 (0%) | 0% | 0 | Common Stock | |
| Irit Arbel | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Nov 2017 | 25,333 | 25,333 | - | - | Stock Option (right to buy) | |
| Robert G.L. Shorr | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Nov 2017 | 8,666 | 45,731 (0%) | 0% | 0 | Common Stock | |
| Malcolm S. Taub | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Nov 2017 | 12,000 | 29,332 (0%) | 0% | 0 | Common Stock | |
| Uri Yablonka | Director, EVP and Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Nov 2017 | 13,333 | 13,333 | - | - | Stock Option (right to buy) | |
| Irit Arbel | None | Purchase of securities on an exchange or from another person at price $ 4.26 per share. | 31 Aug 2017 | 2,500 | 155,833 (0%) | 0% | 4.3 | 10,650 | Common Stock |
| Uri Yablonka | Director, EVP & Chief Business Officer | Purchase of securities on an exchange or from another person at price $ 3.98 per share. | 23 Aug 2017 | 2,000 | 7,543 (0%) | 0% | 4.0 | 7,960 | Common Stock |
| Chaim Lebovits | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jul 2017 | 41,580 | 41,580 | - | - | Stock Option (right to buy) | |
| Chaim Lebovits | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jul 2017 | 31,185 | 2,103,785 (11%) | 0% | 0 | Common Stock | |
| Irit Arbel | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jul 2017 | 12,000 | 12,000 | - | - | Stock Option (right to buy) | |
| Uri Yablonka | Director, EVP & Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jul 2017 | 5,543 | 5,543 (0%) | 0% | 0 | Common Stock | |
| Ralph Kern | COO and Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2017 | 35,885 | 35,885 (0%) | 0% | 0 | Common Stock | |
| Ralph Kern | COO and Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2017 | 47,847 | 47,847 | - | - | Stock Option (right to buy) | |
| Irit Arbel | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2017 | 6,667 | 6,667 | - | - | Stock Option (right to buy) | |
| Arturo O. Araya | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2017 | 3,012 | 3,012 (0%) | 0% | 0 | Common Stock | |
| Robert G.L. Shorr | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2016 | 8,666 | 37,065 | - | - | Common Stock | |
| Irit Arbel | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2016 | 25,333 | 25,333 | - | - | Stock Option (right to buy) | |
| Malcolm S. Taub | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2016 | 8,666 | 17,332 | - | - | Common Stock | |
| Alon Pinkas | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2016 | 15,333 | 15,333 | - | - | Stock Option (right to buy) | |
| Mordechai Friedman | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2016 | 16,666 | 16,666 | - | - | Stock Option (right to buy) | |
| Uri Yablonka | Director, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2016 | 13,333 | 13,333 | - | - | Stock Option (right to buy) | |
| Robert G.L. Shorr | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 16 Dec 2015 | 10,800 | 28,399 | - | - | Common Stock | |
| Malcolm S. Taub | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 14 Dec 2015 | 11,263 | 8,666 | - | - | Common Stock | |
| Malcolm S. Taub | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 14 Dec 2015 | 30,479 | 19,929 | - | - | Common Stock | |
| Mordechai Friedman | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 14 Dec 2015 | 5,000 | 0 | - | - | Common Stock | |
| Mordechai Friedman | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Dec 2015 | 5,000 | 5,000 | - | - | Common Stock | |
| Mordechai Friedman | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Dec 2015 | 5,000 | 11,666 | - | - | Stock Option (right to buy) | |
| Robert G.L. Shorr | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 10 Dec 2015 | 5,300 | 39,199 | - | - | Common Stock | |
| Robert G.L. Shorr | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 10 Dec 2015 | 5,500 | 44,499 | - | - | Common Stock | |
| Malcolm S. Taub | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 10 Dec 2015 | 980 | 50,408 | - | - | Common Stock | |
| Malcolm S. Taub | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 10 Dec 2015 | 12,500 | 51,388 | - | - | Common Stock | |
| Yoram Bibring | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Dec 2015 | 82,500 | 82,500 | - | - | Stock Option (right to buy) | |
| Chaim Lebovits | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Sep 2015 | 369,619 | 369,619 | - | - | Stock Option (right to buy) | |
| Robert G.L. Shorr | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Aug 2015 | 8,666 | 49,999 | - | - | Common Stock | |
| Irit Arbel | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Aug 2015 | 25,333 | 25,333 | - | - | Stock Option (right to buy) | |
| Malcolm S. Taub | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Aug 2015 | 8,666 | 50,554 | - | - | Common Stock | |
| Alon Pinkas | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Aug 2015 | 15,333 | 15,333 | - | - | Stock Option (right to buy) | |
| Mordechai Friedman | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Aug 2015 | 16,666 | 16,666 | - | - | Stock Option (right to buy) | |
| Uri Yablonka | Director, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Aug 2015 | 13,333 | 13,333 | - | - | Stock Option (right to buy) | |
| Yoram Bibring | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 20 Aug 2015 | 8,500 | 50,000 | - | - | Common Stock | |
| Yoram Bibring | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 17 Aug 2015 | 41,500 | 41,500 | - | - | Common Stock | |
| Yoram Bibring | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2015 | 165,000 | 165,000 | - | - | Stock Option (right to buy) | |
| Irit Arbel | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2015 | 6,667 | 6,667 | - | - | Stock Option (right to buy) | |
| Chen Schor | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2015 | 60,000 | 121,558 | - | - | Common Stock | |
| Anthony Fiorino | Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 15 Oct 2014 | 200 | 2,200 | - | - | Common Stock | |
| Anthony Fiorino | Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 15 Oct 2014 | 300 | 2,500 | - | - | Common Stock | |
| Anthony Fiorino | Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 18 Sep 2014 | 800 | 2,000 | - | - | Common Stock | |
| Anthony Fiorino | Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 12 Sep 2014 | 2,500 | 2,500 | - | - | Common Stock | |
| Anthony Fiorino | Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 12 Sep 2014 | 7,500 | 10,000 | - | - | Common Stock | |
| Anthony Fiorino | Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 12 Sep 2014 | 5,000 | 15,000 | - | - | Common Stock | |
| Anthony Fiorino | Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 12 Sep 2014 | 3,000 | 18,000 | - | - | Common Stock | |
| Robert G.L. Shorr | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2014 | 130,000 | 620,000 | - | - | Common Stock | |
| Irit Arbel | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2014 | 380,000 | 380,000 | - | - | Stock Option (right to buy) | |
| Malcolm S. Taub | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2014 | 130,000 | 628,333 | - | - | Common Stock | |
| Alon Pinkas | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2014 | 230,000 | 230,000 | - | - | Stock Option (right to buy) | |
| Mordechai Friedman | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2014 | 250,000 | 250,000 | - | - | Stock Option (right to buy) | |
| Uri Yablonka | Director, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2014 | 200,000 | 200,000 | - | - | Stock Option (right to buy) | |
| Anthony Fiorino | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2014 | 5,700,000 | 5,700,000 | - | - | Stock Option (right to buy) | |
| Uri Yablonka | Director, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2014 | 500,000 | 500,000 | - | - | Stock Option (right to buy) | |
| Abraham Israeli | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Apr 2014 | 166,666 | 166,666 | - | - | Stock Option (right to buy) | |
| Abraham Israeli | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Apr 2014 | 133,334 | 133,334 | - | - | Stock Option (right to buy) | |
| Liat Sossover | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2013 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | |
| Robert G.L. Shorr | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Apr 2013 | 130,000 | 490,000 | - | - | Common Stock | |
| Irit Arbel | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Apr 2013 | 180,000 | 180,000 | - | - | Stock Option (right to buy) | |
| Malcolm S. Taub | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Apr 2013 | 130,000 | 498,333 | - | - | Common Stock | |
| Alon Pinkas | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Apr 2013 | 130,000 | 130,000 | - | - | Stock Option (right to buy) | |
| Mordechai Friedman | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Apr 2013 | 150,000 | 150,000 | - | - | Stock Option (right to buy) | |
| Abraham Israeli | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Apr 2013 | 166,666 | 166,666 | - | - | Stock Option (right to buy) | |
| Robert G.L. Shorr | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2012 | 130,000 | 360,000 | - | - | Common Stock | |
| Irit Arbel | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2012 | 180,000 | 180,000 | - | - | Stock Option (right to buy) | |
| Malcolm S. Taub | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2012 | 130,000 | 368,333 | - | - | Common Stock | |
| Liat Sossover | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2012 | 60,000 | 60,000 | - | - | Stock Option (right to buy) | |
| Alon Pinkas | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2012 | 130,000 | 130,000 | - | - | Stock Option (right to buy) | |
| Adrian Harel | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2012 | 70,000 | 70,000 | - | - | Stock Option (right to buy) | |
| Mordechai Friedman | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2012 | 150,000 | 150,000 | - | - | Stock Option (right to buy) | |
| Abraham Israeli | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Apr 2012 | 166,666 | 166,666 | - | - | Stock Option (right to buy) | |
| Robert G.L. Shorr | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 05 Dec 2011 | 98,333 | 230,000 | - | - | Common Stock | |
| Robert G.L. Shorr | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 28 Nov 2011 | 10,000 | 328,333 | - | - | Common Stock | |
| Chen Schor | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Oct 2011 | 923,374 | 923,374 | - | - | Common Stock | |
| Robert G.L. Shorr | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 04 Oct 2011 | 105,000 | 433,333 | - | - | Common Stock | |
| Robert G.L. Shorr | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 04 Oct 2011 | 95,000 | 338,333 | - | - | Common Stock | |
| Chen Schor | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Aug 2011 | 923,374 | 923,374 | - | - | Common Stock | |
| Adrian Harel | Acting Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2011 | 70,000 | 70,000 | - | - | Stock Option (right to buy) | |
| Robert G.L. Shorr | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2011 | 108,333 | 408,333 | - | - | Common Stock | |
| Robert G.L. Shorr | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2011 | 130,000 | 538,333 | - | - | Common Stock | |
| Irit Arbel | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2011 | 108,333 | 108,333 | - | - | Stock Option (right to buy) | |
| Irit Arbel | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2011 | 180,000 | 180,000 | - | - | Stock Option (right to buy) | |
| Alon Pinkas | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2011 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
| Alon Pinkas | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2011 | 130,000 | 130,000 | - | - | Stock Option (right to buy) | |
| Adrian Harel | Acting Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2011 | 450,000 | 450,000 | - | - | Stock Option (right to buy) | |
| Mordechai Friedman | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2011 | 16,667 | 16,667 | - | - | Stock Option (right to buy) | |
| Mordechai Friedman | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2011 | 150,000 | 150,000 | - | - | Stock Option (right to buy) | |
| Malcolm S. Taub | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 06 Jun 2011 | 33,023 | 0 | - | - | Common Stock | |
| Abraham Israeli | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Apr 2011 | 166,666 | 166,666 | - | - | Stock Option (right to buy) | |
| Robert G.L. Shorr | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2010 | 200,000 | 300,000 | - | - | Common Stock | |
| Malcolm S. Taub | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2010 | 100,000 | 100,000 | - | - | Common Stock | |
| Malcolm S. Taub | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2010 | 108,333 | 208,333 | - | - | Common Stock | |
| Malcolm S. Taub | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2010 | 130,000 | 338,333 | - | - | Common Stock | |
| Malcolm S. Taub | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 16 May 2010 | 100,000 | 238,333 | - | - | Common Stock | |
| Abraham Israeli | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Apr 2010 | 166,666 | 166,666 | - | - | Stock Option (right to buy) | |
| David Stolick | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 12 Feb 2010 | 100,000 | 150,000 | - | - | Common Stock | |
| David Stolick | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2010 | 400,000 | 0 | - | - | Stock Option (right to buy) | |
| David Stolick | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 12 Feb 2010 | 5,000 | 395,000 | - | - | Common Stock | |
| David Stolick | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 12 Feb 2010 | 3,000 | 392,000 | - | - | Common Stock | |
| David Stolick | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 12 Feb 2010 | 140,000 | 252,000 | - | - | Common Stock | |
| David Stolick | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 12 Feb 2010 | 2,000 | 250,000 | - | - | Common Stock | |
| Jonathan C. Javitt | None | 31 Dec 2009 | 960,000 | 960,000 | - | - | Common Stock | ||
| Jonathan C. Javitt | None | 31 Dec 2009 | 213,988 | 746,012 | - | - | Common Stock | ||
| Jonathan C. Javitt | None | 31 Dec 2009 | 50,000 | 696,012 | - | - | Common Stock | ||
| Jonathan C. Javitt | None | 31 Dec 2009 | 2,800 | 693,212 | - | - | Common Stock | ||
| Jonathan C. Javitt | None | 31 Dec 2009 | 5,224 | 687,988 | - | - | Common Stock | ||
| Jonathan C. Javitt | None | 31 Dec 2009 | 87,509 | 600,479 | - | - | Common Stock | ||
| Jonathan C. Javitt | None | 31 Dec 2009 | 48,869 | 551,610 | - | - | Common Stock | ||
| Jonathan C. Javitt | None | 31 Dec 2009 | 60,000 | 491,610 | - | - | Common Stock | ||
| Jonathan C. Javitt | None | 31 Dec 2009 | 31,610 | 460,000 | - | - | Common Stock | ||
| Irit Arbel | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2009 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | |
| Robert G.L. Shorr | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 16 Oct 2009 | 5,000 | 295,000 | - | - | Common Stock | |
| Robert G.L. Shorr | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 16 Oct 2009 | 50,000 | 245,000 | - | - | Common Stock | |
| Robert G.L. Shorr | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 16 Oct 2009 | 50,000 | 195,000 | - | - | Common Stock | |
| Robert G.L. Shorr | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 16 Oct 2009 | 25,000 | 170,000 | - | - | Common Stock | |
| Robert G.L. Shorr | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 16 Oct 2009 | 10,000 | 140,000 | - | - | Common Stock | |
| Robert G.L. Shorr | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 16 Oct 2009 | 20,000 | 140,000 | - | - | Common Stock | |
| Robert G.L. Shorr | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 16 Oct 2009 | 40,000 | 100,000 | - | - | Common Stock | |
| Malcolm S. Taub | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 14 Sep 2009 | 350,000 | 900,000 | - | - | Common Stock | |
| Malcolm S. Taub | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 14 Sep 2009 | 225,000 | 675,000 | - | - | Common Stock | |
| Irit Arbel | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Aug 2009 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | |
| Moshe Lion | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Aug 2009 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | |
| David Stolick | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2009 | 200,000 | 200,000 | - | - | Stock Option (right to buy) | |
| Abraham (Rami) Efrati | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2009 | 1,000,000 | 1,000,000 | - | - | Stock Option (right to buy) | |
| Malcolm S. Taub | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Mar 2009 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | |
| Robert G.L. Shorr | None | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 24 Oct 2007 | 100,000 | 300,000 | - | - | Common Stock | |
| Irit Arbel | None | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 23 Oct 2007 | 100,000 | 0 | - | - | Stock Option (right to buy) | |
| Michael Greenfield (Ben-Ari) | Other | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 23 Oct 2007 | 100,000 | 300,000 | - | - | Common Stock | |
| Abraham (Rami) Efrati | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Oct 2007 | 1,000,000 | 1,000,000 | - | - | Stock Option (right to buy) | |
| Jonathan C. Javitt | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Aug 2007 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | |
| Moshe Lion | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2007 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | |
| Robert G.L. Shorr | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2007 | 100,000 | 400,000 | - | - | Common Stock | |
| Irit Arbel | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2007 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | |
| Michael Greenfield (Ben-Ari) | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2007 | 100,000 | 400,000 | - | - | Common Stock | |
| Robert G.L. Shorr | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2007 | 100,000 | 300,000 | - | - | Common Stock | |
| Irit Arbel | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2007 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | |
| Yoram Drucker | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2007 | 250,000 | 250,000 | - | - | Stock Option (right to buy) | |
| Michael Greenfield (Ben-Ari) | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2007 | 100,000 | 300,000 | - | - | Common Stock | |
| David Stolick | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2007 | 350,000 | 350,000 | - | - | Stock Option (right to buy) | |
| Irit Arbel | None | Sale or transfer of securities back to the company at price $ 0.00 per share. | 17 Sep 2006 | 100,000 | 0 | - | - | Stock Option (right to buy) | |
| Irit Arbel | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Sep 2006 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | |
| Robert G.L. Shorr | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2006 | 100,000 | 200,000 | - | - | Common Stock | |
| Irit Arbel | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2006 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | |
| Yoram Drucker | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2006 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | |
| Michael Greenfield (Ben-Ari) | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2006 | 100,000 | 200,000 | - | - | Common Stock | |
| David Stolick | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2006 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | |
| David Stolick | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 06 Feb 2006 | 400,000 | 0 | - | - | Stock Option (right to buy) | |
| David Stolick | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2006 | 400,000 | 400,000 | - | - | Stock Option (right to buy) | |
| Robert G.L. Shorr | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2005 | 100,000 | 100,000 | - | - | Common Stock | |
| Irit Arbel | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2005 | 100,000 | 100,000 | - | - | Stock option (right to buy) | |
| Michael Greenfield (Ben-Ari) | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2005 | 100,000 | 100,000 | - | - | COMMON STOCK | |
| David Stolick | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2005 | 400,000 | 400,000 | - | - | Stock Option (right to buy) | |
| Yaffa Beck | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2004 | 1,828,692 | 1,828,692 | - | - | Stock Option (right to buy) | |
| Yoram Drucker | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2004 | 685,760 | 685,760 | - | - | Stock Option (Right to Buy) | |
| Frankenberger Mike | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2004 | 100,000 | 7,000,000 | - | - | Common Stock | |
| Frankenberger Mike | Director, Ten Percent Owner | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 May 2004 | 6,880,000 | 120,000 | - | - | Common Stock | |
| Frankenberger Mike | Other | Other type of transaction at price $ 0.00 per share. | 05 Dec 2003 | 8,500,000 | 8,462,000 | - | - | Common Stock .00005 Par Value | |
| Frankenberger Mike | Other | Other type of transaction at price $ 0.00 per share. | 05 Dec 2003 | 1,562,000 | 6,900,000 | - | - | Common Stock .00005 Par Value | |
| Frankenberger Mike | Other | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 05 Dec 2003 | 100,000 | 7,000,000 | - | - | Common Stock .00005 Par Value | |
| Frankenberger Mike | Other | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 05 Dec 2003 | 6,880,000 | 120,000 | - | - | Common Stock .00005 Par Value | |
| Frankenberger Mike | Other | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 05 Dec 2003 | 20,000 | 140,000 | - | - | Common Stock .00005 Par Value | |
| Frankenberger Mike | Other | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 05 Dec 2003 | 15,000 | 155,000 | - | - | Common Stock .00005 Par Value |